PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsTheravance Biopharma
Theravance Biopharma(TBPH)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
VibativTelavancin2011-09-022027
Pneumonia
,
Cross infection
,
Bacterial infections
,
Infectious skin diseases
,
Streptococcal infections
,
Bacterial pneumonia
,
Staphylococcal infections
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Telavancin
healthy volunteers/patients
,
bacterial infections
,
gram-positive bacterial infections
,
wound infection
,
abscess
,
ulcer
,
burns
,
cellulitis
,
infections
,
communicable diseases
,
sepsis
,
staphylococcal infections
,
bacterial pneumonia
,
bacteremia
,
staphylococcal skin infections
,
healthcare-associated pneumonia
,
chronic kidney failure
,
kidney diseases
,
fibrosis
,
cystic fibrosis
,
chronic renal insufficiency
,
subarachnoid hemorrhage
,
pneumonia
,
pregnancy
Ampreloxetine
drug interactions
,
hypertension
,
myofascial pain syndromes
,
fibromyalgia
,
shy-drager syndrome
,
atrophy
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
orthostatic hypotension
,
hypotension
,
pure autonomic failure
,
parkinson disease
,
multiple system atrophy
AXELOPRAN
opioid-induced constipation
,
constipation
,
healthy volunteers/patients
,
prostatic neoplasms
,
breast neoplasms
,
pancreatic neoplasms
,
neoplasms
,
lung neoplasms
,
recurrence
,
squamous cell carcinoma of head and neck
,
neoplasm metastasis
BATEFENTEROL
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
CEFILAVANCIN
staphylococcal skin infections
,
staphylococcal infections
FELCISETRAG
healthy volunteers/patients
,
critical illness
,
enteral nutrition
Izencitinib
inflammatory bowel diseases
,
intestinal diseases
,
healthy volunteers/patients
,
crohn disease
,
gastroparesis
,
ulcerative colitis
,
colitis
,
ulcer
VELUSETRAG
alzheimer disease
,
gastroparesis
,
constipation
,
intestinal pseudo-obstruction
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use